NVDA Q3 Earnings Alert: Why our AI share picker is still holding Nvidia sharesRead More

Markets Start Potentially Vaccine-Heavy December On Front Foot

Published 01/12/2020, 09:06
UK100
-
FCHI
-
DJI
-
DE40
-
PFE
-
MRNA
-
BNTX
-

After tying up loose ends yesterday, the markets entered the final month of the year fresh-faced and ready to rally.

December is set see the Pfizer/BioNTech and Moderna (NASDAQ:MRNA) vaccines given emergency use authorisation in the UK, US and elsewhere, the rollout of which should be the first major step towards escaping the clutches of the pandemic.

Knowledge of this – including confirmation that the Moderna preparation is 94% after the final results were posted yesterday – appears to be helping the markets lift higher this Tuesday, recovering from Monday’s November-ending wobble.

Climbing 0.9%, the FTSE once again found itself at 6,350, a level it has repeatedly found itself returning to in the last few weeks. The challenge for the UK index this month will be sustainably rising past 6,400 and staying there, something it tried and failed to do multiple times in November.

The FTSE’s gains come alongside a sharp 0.5% increase for cable, which rose beyond $1.34 for the first time since early September thanks more to dollar weakness than anything else. Sterling did also add 0.1% against the euro, however, despite reports of an ‘impatient’ EU that will not fall into a Brexit ‘negotiating trap’.

Over in the Eurozone the DAX struck a 9-month-plus peak of 13,400 after jumping 0.7%, while the CAC stuck its nose above 5,560 following a 0.3% increase.

In a positive sign for Europe, the Dow Jones is aiming for a 320 point surge when trading gets started stateside, a move that would leave it around 20 points adrift of that magic 30,000 milestone. It is going to be real interesting to see whether investors can find enough justification against a violent covid-19 backdrop to allow the Dow to end the year significantly above that record level.

"Disclaimer: Spreadex provides an execution only service and the comments above do not constitute (or should not be construed as constituting) investment advice or recommendations, or a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any person placing trades based on their interpretations of the above comments does so entirely at their own risk. Spreadex Ltd is a financial and sports spread betting and sports fixed odds betting firm, which specialises in the personal service and credit area. Founded in 1999, Spreadex is recognised as one of the longest established spread betting firms in the industry with a strong reputation for its high level of customer service and account management.

In relation to spread betting, Spreadex Ltd is authorised and regulated by the Financial Conduct Authority. Spread betting carries a high level of risk to your capital and can result in losses larger than your initial stake/deposit. It may not be suitable for everyone, so please ensure you fully understand the risks involved."

Original Post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.